(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
(Address of principal executive offices) |
(Zip Code) |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class |
Trading symbol |
Name of each exchange on which registered | ||
Item 8.01 |
Other Events |
Item 9.01 |
Financial Statements and Exhibits |
Exhibit No. |
Description | |
23.1 |
||
99.1 |
||
104 |
Cover Page Interactive Data file (embedded within the Inline XBRL document). |
HIMS & HERS HEALTH, INC. | ||||||
DATE: February 4, 2022 |
By: |
/s/ Andrew Dudum | ||||
Andrew Dudum | ||||||
Chief Executive Officer |